Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Dorian

Showing results (21-30 of 132) with videos related to

Pageof 14
Sort By:
American Heart Journal|April 1, 1994
The impact of left ventricular dysfunction on outcomes with the implantable defibrillatorP Dorian, S Connolly, S Yusuf
International Journal of Clinical Practice|January 23, 1999
Implantable defibrillators and/or amiodarone: alternatives or complementary therapiesP Dorian, D Newman, M Greene
Drugs|January 11, 2001
Can antiarrhythmic agents be selected based on mechanism of action?W Lau, D Newman, P Dorian
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|April 4, 2021
The Association Between Same-Sex Marriage Legalization and Youth Deaths by Suicide: A Multimethod Counterfactual AnalysisAndrew Kennedy, Murat Genç, P Dorian Owen
The Canadian Journal of Cardiology|March 1, 1997
Emergency arrhythmia management: an assessment of learning needsB A Morris, G Dickinson, P Dorian
Canadian Journal of Physiology and Pharmacology|October 1, 1993
Isoproterenol antagonizes drug-induced prolongation of action potential duration in humansD Newman, P Dorian, R Feder-Elituv
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|June 4, 1999
Azimilide decreases defibrillation voltage requirements and increases spatial organization during ventricular fibrillationX Q Qi, D Newman, P Dorian
Journal of Cardiovascular Pharmacology|February 1, 1992
Isoproterenol increases defibrillation energy requirements in dogsM Wang, P Dorian, R I Ogilvie
Journal of Cardiovascular Pharmacology|December 22, 1999
The class III effect of azimilide is not associated with reverse use-dependence in open-chest dogsX Q Qi, D Newman, P Dorian
Journal of Evaluation in Clinical Practice|April 4, 2006
The impact of implantable cardiac defibrillators for primary prophylaxis in the community: baseline risk and clinically meaningful benefitsS Jolly, P Dorian, D A Alter
Pageof 14

Showing results (21-30 of 132) with videos related to

Sort By:
Pageof 14
American Heart Journal|April 1, 1994
The impact of left ventricular dysfunction on outcomes with the implantable defibrillatorP Dorian, S Connolly, S Yusuf
International Journal of Clinical Practice|January 23, 1999
Implantable defibrillators and/or amiodarone: alternatives or complementary therapiesP Dorian, D Newman, M Greene
Drugs|January 11, 2001
Can antiarrhythmic agents be selected based on mechanism of action?W Lau, D Newman, P Dorian
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|April 4, 2021
The Association Between Same-Sex Marriage Legalization and Youth Deaths by Suicide: A Multimethod Counterfactual AnalysisAndrew Kennedy, Murat Genç, P Dorian Owen
The Canadian Journal of Cardiology|March 1, 1997
Emergency arrhythmia management: an assessment of learning needsB A Morris, G Dickinson, P Dorian
Canadian Journal of Physiology and Pharmacology|October 1, 1993
Isoproterenol antagonizes drug-induced prolongation of action potential duration in humansD Newman, P Dorian, R Feder-Elituv
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|June 4, 1999
Azimilide decreases defibrillation voltage requirements and increases spatial organization during ventricular fibrillationX Q Qi, D Newman, P Dorian
Journal of Cardiovascular Pharmacology|February 1, 1992
Isoproterenol increases defibrillation energy requirements in dogsM Wang, P Dorian, R I Ogilvie
Journal of Cardiovascular Pharmacology|December 22, 1999
The class III effect of azimilide is not associated with reverse use-dependence in open-chest dogsX Q Qi, D Newman, P Dorian
Journal of Evaluation in Clinical Practice|April 4, 2006
The impact of implantable cardiac defibrillators for primary prophylaxis in the community: baseline risk and clinically meaningful benefitsS Jolly, P Dorian, D A Alter
Pageof 14